• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Everest Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4614.0
  • ISIN : INE334C01029
252.00 2 (0.80%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    238.60

  • Today’s High

    253.35

  • Open

    250.00

  • Perv Close

    250.00

  • 52W Low

    112.45

  • 52W High

    307.15

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    244.71

  • Div & Yield %

    0.00

  • Book Value(₹)

    68.47

  • Debt-Equity Ratio

    0.80

  • AGM Date

    28-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    244.71

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.71

  • BV (₹)

    68.50

  • Sales( ₹ in Cr.)

    197.24

  • NP (in Cr.)

    0.14

  • NP Var(%)

    280.0

  • Div%

    0.0

  • CPS (₹)

    6.10

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    244.71

  • 52 Week High

    307.15

  • 52 Week Low

    112.45

  • Price BSE

    252.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    244.71

  • P/C Ratio

    41.20

  • P/E Ratio

    1,757.90

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 226.49 208.73 230.22 207.36 189.61 177.77
Excise Duty 226.49 208.68 230.22 207.34 189.57 177.71
Net Sales 226.49 208.73 230.22 207.36 189.61 177.77
Other Income 0.89 6.94 2.21 1.06 1.45 0.54
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 198.13 189.99 202.26 182.63 168.67 156.39
EXPENDITURE :
Raw Materials 226.49 208.68 230.22 207.34 189.57 177.71
Power & Fuel Cost 226.49 208.68 230.22 207.34 189.57 177.71
Employee Cost 18.80 16.30 16.33 15.26 13.30 11.64
Other Manufacturing Expenses 0.96 0.44 0.92 0.64 3.10 1.75
Selling & Administrative Expenses 10.63 9.86 8.78 7.75 7.42 6.39
Miscellaneous Expenses 0.96 0.44 0.92 0.64 3.10 1.75
Less : Pre-operative Expenses Capitalised :
Total Expenditure 197.52 189.90 200.52 165.36 154.57 144.07
Operating Profit 31.89 33.85 31.74 27.31 27.62 24.67
Interest 5.47 3.31 3.10 3.26 3.43 3.21
Gross Profit 0.61 0.09 1.74 17.27 14.09 12.33
Depreciation 5.80 4.47 3.80 3.37 3.21 2.84
Profit Before Tax 0.61 0.09 1.74 17.27 14.09 12.33
Tax 0.10 0.02 0.29 3.02 2.27 2.70
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.37 0.26 0.31 0.54 0.93 2.12
Reported Net Profit 0.14 -0.18 1.14 13.72 10.90 7.51
Extraordinary Items 0.61 0.09 1.74 17.27 14.09 12.33
Adjusted Net Profit 0.14 -0.18 1.14 13.72 10.90 7.51
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 1.20 0.80 0.80
P & L Balance carried down 0.14 -0.18 1.14 13.72 10.90 7.51
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 15.00 10.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.50 1.00 1.00
Earnings Per Share-Unit Curr 0.17 -0.23 1.43 17.14 13.62 9.39
Book Value 0.00 0.00 0.00 1.20 0.80 0.80
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 1.20 0.80 0.80

Shareholding Pattern

  • Promoter Group

    61.09%

  • Public Share Holding

    38.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 169,128 169,128.00 169,128 169,128
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 169,128 1.74 169,128 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,949,262 40.67 3,949,262 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,813,641 18.68 1,813,641 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,762,903 59.35 5,762,903 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,214 0.02 2,214 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 36 0.00 36 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,250 0.02 2,250 3
2] Non Institution
Bodies Corporate 376,457 3.88 369,041 56
Clearing Members 200 0.00 200 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 257,991 2.66 189,555 155
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,950,623 20.09 1,950,623 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,177,726 12.13 926,806 8,560
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 13,248 0.14 13,248 1
Sub Total 3,776,245 38.89 3,449,473 8,782
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,710,526 100.00 9,383,754 8,795

Company Background

Everest Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Everest Organics Ltd
  • BSE Code : 4614.0
  • ISIN : INE334C01029

  • Incorporation Year

    1993

  • Registered Office

    Aroor Village
    Sadasivpet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-8455-250113

  • FAX

    91-8455-250114

  • Chairman

  • Managing Director

  • Company Secretary

    Abdur Rahman

  • Auditor

    P S N Ravishanker & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Everest Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Everest Organics 252.00 198.13 226.49 -59.02 5.94
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92